4Larime S.A Alfa Wassermann S.P.A INT.J.CLIN.PHARM.RES. Pharmacokinetic study of Rifaximin after oral administration in healthy volunteers XI V (2)51-56.
8Scrascia M, Forcillo M, Maimone F, et al. Susceptibility to ri- faximin of Vibrio cholerae strains from different geographical areas[J].Antimiero Chem,2003,52 : 303.
9Lu J R, Umelaal I M, Barry harmon, et al. Diversity and succes- sion of the intestinal bacterial community of the maturing broiler chicken[J]. AppI Environ Microbiol, 2003,11 : 6816-6824.
10Gary R. Lichtenstein. Rifaximin: recent advantages in gastro- enterology and hepatology[J]. Gastroenterol & Hepatol, 2007,3(6) :474-483.
